Holen Sie sich die Stockscreener-App
70.06
0.97%
0.67
Handel nachbörslich:
70.06
Schlusskurs vom Vortag:
$69.39
Offen:
$70.28
24-Stunden-Volumen:
823.61K
Relative Volume:
0.65
Marktkapitalisierung:
$9.95B
Einnahmen:
$2.48B
Nettoeinkommen (Verlust:
$91.51M
KGV:
104.57
EPS:
0.67
Netto-Cashflow:
$293.77M
1W Leistung:
-3.17%
1M Leistung:
-4.80%
6M Leistung:
-4.46%
1J Leistung:
+36.70%
1-Tages-Spanne:
$69.12
$70.48
1-Wochen-Bereich:
$68.56
$72.50
52-Wochen-Spanne:
$49.33
$94.93
Globus Medical Inc Stock (GMED) Company Profile
Firmenname
Globus Medical Inc
Sektor
Branche
Telefon
610-930-1800
Adresse
2560 GENERAL ARMISTEAD AVENUE, AUDUBON, PA
Vergleichen Sie GMED mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
GMED
Globus Medical Inc
|
70.06 | 9.95B | 2.48B | 91.51M | 293.77M | 0.67 |
|
ABT
Abbott Laboratories
|
131.73 | 218.91B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
95.05 | 139.37B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
348.12 | 134.90B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
83.37 | 106.90B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
70.60 | 41.45B | 5.72B | 4.17B | 259.90M | 6.97 |
Globus Medical Inc Stock (GMED) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-01-10 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2024-12-02 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2024-08-07 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2024-05-20 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2024-03-18 | Hochstufung | BTIG Research | Neutral → Buy |
| 2023-10-20 | Eingeleitet | ROTH MKM | Buy |
| 2023-09-19 | Hochstufung | Stifel | Hold → Buy |
| 2023-03-30 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2023-02-13 | Herabstufung | BofA Securities | Buy → Underperform |
| 2023-02-10 | Herabstufung | BTIG Research | Buy → Neutral |
| 2023-02-10 | Herabstufung | Loop Capital | Buy → Hold |
| 2023-02-10 | Herabstufung | Needham | Buy → Hold |
| 2023-02-10 | Herabstufung | Truist | Buy → Hold |
| 2023-02-10 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2022-10-18 | Eingeleitet | Barclays | Overweight |
| 2022-10-12 | Eingeleitet | Jefferies | Buy |
| 2022-04-13 | Fortgesetzt | Truist | Buy |
| 2022-03-28 | Eingeleitet | Wells Fargo | Overweight |
| 2022-01-04 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2021-12-13 | Hochstufung | BofA Securities | Underperform → Buy |
| 2021-12-10 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2021-10-29 | Eingeleitet | Loop Capital | Buy |
| 2021-02-18 | Fortgesetzt | Needham | Buy |
| 2020-12-08 | Eingeleitet | Citigroup | Buy |
| 2020-10-20 | Eingeleitet | Stifel | Hold |
| 2020-08-06 | Bestätigt | Needham | Buy |
| 2020-08-06 | Hochstufung | Northland Capital | Market Perform → Outperform |
| 2020-07-21 | Eingeleitet | Northland Capital | Market Perform |
| 2020-07-06 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2020-05-08 | Bestätigt | Needham | Buy |
| 2020-03-18 | Hochstufung | BTIG Research | Neutral → Buy |
| 2020-01-08 | Eingeleitet | SunTrust | Buy |
| 2019-12-12 | Hochstufung | Wells Fargo | Market Perform → Outperform |
| 2019-08-02 | Bestätigt | Needham | Buy |
| 2019-05-24 | Herabstufung | Wells Fargo | Outperform → Market Perform |
| 2019-05-03 | Bestätigt | Needham | Buy |
| 2019-02-28 | Hochstufung | UBS | Neutral → Buy |
| 2019-01-02 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2018-08-02 | Bestätigt | Needham | Buy |
| 2018-06-27 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2018-06-01 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2018-05-03 | Bestätigt | Needham | Buy |
| 2018-04-04 | Hochstufung | Needham | Hold → Buy |
Alle ansehen
Globus Medical Inc Aktie (GMED) Neueste Nachrichten
Why Globus Medical (GMED) is a Top Growth Stock for the Long-Term - Yahoo Finance
Is the Options Market Predicting a Spike in Globus Medical (GMED) Stock? - TradingView
Globus Medical to Announce Q1 2025 Results and Host Investor Call - MSN
Robotic-assisted Surgery Systems Market Future Business - openPR.com
Impingement Syndrome Market Future Business Opportunities - openPR.com
International Growth Drives GMED Stock Amid Fierce Competition - MSN
An Intrinsic Calculation For Globus Medical, Inc. (NYSE:GMED) Suggests It's 38% Undervalued - simplywall.st
Will Globus Medical (GMED) Beat Estimates Again in Its Next Earnings Report? - Yahoo Finance
Spine Surgery Robots Market Size, Share, Trends, Competitive - openPR.com
Globus Medical Schedules First Quarter Earnings Release and Conference Call - GlobeNewswire
Globus Medical Schedules First Quarter Earnings Release and Conference Call | GMED Stock News - GuruFocus
Globus Medical, Inc. Scheduled to Release Q1 2025 Financial Results on May 8, 2025 - Nasdaq
Globus Medical Announces Q1 Earnings Date: Leading Musculoskeletal Tech Firm Reports May 8 - Stock Titan
Here's How Much You Would Have Made Owning Globus Medical Stock In The Last 10 Years - Benzinga
Interspinous Spacers Market Deep Research Report with Forecast to 2032 | Alphatec Spine, Inc., Globus Medical - openPR.com
Is The Market Rewarding Globus Medical, Inc. (NYSE:GMED) With A Negative Sentiment As A Result Of Its Mixed Fundamentals? - Yahoo Finance
BTIG Revises Price Target for Globus Medical (GMED) Amid MedTech - GuruFocus
Spinal Column Market Deep Research Report with Forecast by 2032 | - openPR.com
Orthobiologics Market Set to Witness Significant Growth - openPR.com
Truist Adjusts Price Target for Globus Medical (GMED) to $80 | G - GuruFocus
Breaking Down Globus Medical: 5 Analysts Share Their Views - Benzinga
Truist Trims Price Target on Globus Medical to $80 From $82, Keeps Hold Rating - marketscreener.com
GMED Stock May Benefit Following the Acquisition of Nevro - MSN
JMP maintains Market Perform on Globus Medical stock By Investing.com - Investing.com Canada
Intramedullary Nail Market size to worth USD 1,537 Million by 2032, says Coherent Market Insights - GlobeNewswire Inc.
Degenerative Disc Disease Treatment Market Set to Witness - openPR.com
This Globus Medical Insider Reduced Their Stake By 100% - simplywall.st
Globus acquires US medical device company Nevro - Yahoo Finance
Globus Medical Completes Acquisition of Nevro Corp. - MyChesCo
Nevro Corp completes merger with Globus Medical - Investing.com Australia
Globus Medical Closes Acquisition of Nevro - MarketScreener
Globus Medical Acquires Nevro Corp. - citybiz
Nevro Corp completes merger with Globus Medical By Investing.com - Investing.com South Africa
Globus Medical completes acquisition of Nevro Corp. - GlobeNewswire
Major Medical Tech Merger: Globus Medical's $2.5B Market Push Through Nevro Acquisition - Stock Titan
Globus Medical, Inc. (NYSE:GMED) Shares Bought by Vanguard Group Inc. - MarketBeat
$100 Invested In Globus Medical 10 Years Ago Would Be Worth This Much Today - Benzinga
Robotic-assisted Surgery Systems Market Set to Witness - openPR.com
Total Disc Replacement Market Future Business Opportunities - openPR.com
Levi & Korsinsky Reminds Shareholders of an Investigation into Globus Medical, Inc. (GMED) Regarding Potential Securities Fraud Allegations - ACCESS Newswire
Despite the downward trend in earnings at Globus Medical (NYSE:GMED) the stock grows 7.0%, bringing five-year gains to 80% - Yahoo Finance
Orthobiologics Market Future Business Opportunities - openPR
New Product Launches Benefit GMED Stock Amid Macro Issues - MSN
Finanzdaten der Globus Medical Inc-Aktie (GMED)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.32%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):